Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 32993738)

  • 1. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
    Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
    Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
    Zhang X; Shi L; Sun HD; Wang ZW; Xu F; Wei JF; Ding Q
    Clin Transl Med; 2023 Sep; 13(9):e1427. PubMed ID: 37743642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer.
    Jiang L; Li Y; He Y; Wei D; Yan L; Wen H
    Front Oncol; 2021; 11():711207. PubMed ID: 34621671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
    Du M; Peng Y; Li Y; Sun W; Zhu H; Wu J; Zong D; Wu L; He X
    Cell Death Discov; 2022 Feb; 8(1):53. PubMed ID: 35136045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis.
    Wu T; Zhang X; Xing L; Pan D; Liu P; Ding R; Yang R; Yang X; Li Y
    Dis Markers; 2022; 2022():5883101. PubMed ID: 35677634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
    Kim GW; Siddiqui A
    J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.
    Fan J; Zhuang M; Fan W; Hou M
    PeerJ; 2023; 11():e15706. PubMed ID: 37663284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
    Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
    Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.
    Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL
    J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N
    Zheng X; Li S; Yu J; Dai C; Yan S; Chen G; Sun C
    Transl Cancer Res; 2023 Apr; 12(4):992-1005. PubMed ID: 37180667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
    Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
    [No Abstract]   [Full Text] [Related]  

  • 19. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
    Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.